Migraine-preventive prescription patterns by physician specialty in ambulatory care settings in the United States

Allais, 2012, Treatment strategies for menstrually related migraine, Women Health, 8, 529, 10.2217/WHE.12.37 Bagnato, 2016, The use of antiepileptics in migraine prophylaxis, Headache, 56, 603, 10.1111/head.12781 Banzi, 2016, Selective serotonin reuptake inhibitors (SSRIs) and serotonin- norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension-type headache in adults (review), Cochrane Database Syst. Rev., 5 Bigal, 2008, Chronic migraine in the population: burden, diagnosis, and satisfaction with treatment, Neurology, 71, 559, 10.1212/01.wnl.0000323925.29520.e7 Brandes, 2006, The influence of estrogen on migraine: a systematic review, JAMA, 295, 1824, 10.1001/jama.295.15.1824 Breslau, 1991, Migraine, psychiatric disorders, and suicide attempts: an epidemiologic study of young adults, Psychiatry Res., 37, 11, 10.1016/0165-1781(91)90102-U Burch, 2015, The prevalence and burden of migraine and severe headache in the United States: updated statistics from government health surveillance studies, Headache, 55, 21, 10.1111/head.12482 Centers for Disease Control and Prevention Centers for Disease Control and Prevention Chen, 2012, Comorbidity profiles of chronic migraine sufferers in a national database in Taiwan, J. Headache Pain, 13, 311, 10.1007/s10194-012-0447-4 D'Amico, 2006, Improvement in quality of life and activity limitations in migraine patients after prophylaxis. A prospective longitudinal multicentre study, Cephalalgia, 26, 691, 10.1111/j.1468-2982.2005.01094.x Dekker, 2012, Prophylactic treatment of migraine; the patient's view, a qualitative study, BMC Fam. Pract., 13, 13, 10.1186/1471-2296-13-13 Dekker, 2012, Prophylactic treatment of migraine by GPs: a qualitative study, Br. J. Gen. Pract., 62, 10.3399/bjgp12X636100 Dekker, 2013, Preventive treatment for migraine in primary care, a population-based study in the Netherlands, Cephalalgia, 33, 1170, 10.1177/0333102413490343 Diamond, 2007, Patterns of diagnosis and acute and preventive treatment for migraine in the United States: results from the American migraine prevalence and prevention study, Headache, 47, 355 Dodick, 2007, Migraine prevention, Pract. Neurol., 7, 383, 10.1136/jnnp.2007.134023 Hazard, 2009, The burden of migraine in the United States: current and emerging perspectives on disease management and economic analysis, Value Health, 12, 55, 10.1111/j.1524-4733.2008.00404.x Hu, 2013, Triptans in prevention of menstrual migraine: a systematic review with meta-analysis, J. Headache Pain, 14, 7, 10.1186/1129-2377-14-7 Kol, 2008, Acceptance or rejection of prophylactic medicine in patients with migraine: a cross-sectional study, Br. J. Gen. Pract., 58, 98, 10.3399/bjgp08X264063 Linde, 2004, Attitudes and burden of disease among self-considered migraineurs - a nation-wide population-based survey in Sweden, Cephalalgia, 24, 455, 10.1111/j.1468-2982.2004.00703.x Linde, 2015, Efficacy and acceptability of pharmacological treatments for depressive disorders in primary care: systematic review and network meta-analysis, Ann. Fam. Med., 13, 69, 10.1370/afm.1687 Lipton, 2001, Prevalence and burden of migraine in the United States: data from the American migraine study II, Headache, 41, 646, 10.1046/j.1526-4610.2001.041007646.x Lipton, 2007, Migraine prevalence, disease burden, and the need for preventive therapy, Neurology, 68, 343, 10.1212/01.wnl.0000252808.97649.21 Loder, 2012, The 2012 AHS/AAN guidelines for prevention of episodic migraine: a summary and comparison with other recent clinical practice guidelines, Headache, 52, 930, 10.1111/j.1526-4610.2012.02185.x Lumley Mafi, 2015, Trends in the ambulatory management of headache: analysis of NAMCS and NHAMCS data 1999–2010, J. Gen. Intern. Med., 30, 548, 10.1007/s11606-014-3107-3 Marmura, 2014, Safety of topiramate for treating migraines, Expert Opin. Drug Saf., 13, 1241, 10.1517/14740338.2014.934669 Martin, 2008, Epidemiology and biology of menstrual migraine, Headache, 48, S124, 10.1111/j.1526-4610.2008.01310.x McCaig, 2012, Understanding and interpreting the National Hospital Ambulatory Medical Care Survey: key questions and answers, Ann. Emerg. Med., 60, 10.1016/j.annemergmed.2012.07.010 McGill, 2010, Optimal use of beta-blockers in high-risk hypertension: a guide to dosing equivalence, Vasc. Health Risk Manag., 6, 363, 10.2147/VHRM.S6668 Minen, 2016, Migraine diagnosis and treatment: a knowledge and needs assessment among primary care providers, Cephalalgia, 36, 358, 10.1177/0333102415593086 Minen, 2016, A migraine management training program for primary care providers: an overview of a survey and pilot study findings, lessons learned, and considerations for further research, Headache, 56, 725, 10.1111/head.12803 R Development Core Team, 2011 Shamliyan, 2013, Preventive pharmacologic treatments for episodic migraine in adults, J. Gen. Intern. Med., 28, 1225, 10.1007/s11606-013-2433-1 Shapiro, 2012, Preventive treatment of migraine, Headache, 52, 65, 10.1111/j.1526-4610.2012.02242.x Silberstein, 2000, Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the quality standards subcommittee of the American Academy of Neurology, Neurology, 55, 754, 10.1212/WNL.55.6.754 Silberstein, 2015, Preventive migraine treatment, CONTINUUM Lifelong Learn. Neurol., 10.1212/CON.0000000000000199 Silberstein, 2012, Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults, Neurology, 78, 1337, 10.1212/WNL.0b013e3182535d20 Wang, 2017, Increased risk of rheumatoid arthritis in patients with migraine: a population-based, propensity score-matched cohort study, Rheumatol. Int., 37, 273, 10.1007/s00296-016-3604-2 Xu, 2017, Tricyclic antidepressants for preventing migraine in adults, Medicine, 96, 10.1097/MD.0000000000006989